Nomura Asset Management Co. Ltd. Boosts Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Nomura Asset Management Co. Ltd. lifted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) by 8.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 376,600 shares of the real estate investment trust’s stock after acquiring an additional 28,400 shares during the quarter. Nomura Asset Management Co. Ltd. owned 0.15% of Sabra Healthcare REIT worth $7,133,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Rothschild Investment LLC increased its position in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares during the period. Founders Capital Management purchased a new stake in shares of Sabra Healthcare REIT during the third quarter worth $28,000. Strengthening Families & Communities LLC purchased a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth $29,000. Danske Bank A S purchased a new position in Sabra Healthcare REIT in the third quarter valued at $30,000. Finally, Larson Financial Group LLC increased its holdings in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on SBRA shares. Citizens Jmp lifted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Citigroup upped their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. Weiss Ratings cut Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st. Truist Financial upped their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Finally, Wells Fargo & Company upped their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $22.40.

Check Out Our Latest Analysis on Sabra Healthcare REIT

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $18.09 on Thursday. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $21.28. The company has a market capitalization of $4.56 billion, a PE ratio of 28.71, a P/E/G ratio of 1.39 and a beta of 0.64. The company has a fifty day moving average of $20.22 and a two-hundred day moving average of $19.70.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. During the same quarter in the prior year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.6%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Sabra Healthcare REIT Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Further Reading

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.